scispace - formally typeset
T

Takanori Matsuki

Researcher at Osaka University

Publications -  34
Citations -  183

Takanori Matsuki is an academic researcher from Osaka University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 5, co-authored 25 publications receiving 75 citations.

Papers
More filters
Journal ArticleDOI

Antitumor effect of Batf2 through IL-12 p40 up-regulation in tumor-associated macrophages.

TL;DR: It is found that basic leucine zipper transcription factor ATF-like 2 (Batf2) has an antitumor effect through the up-regulation of IL-12 p40 in tumor-associated macrophages, which eventually induces CD8+ T-cell activation and accumulation within the tumor.
Journal ArticleDOI

Long-Term Treatment Outcome of Progressive Mycobacterium Avium Complex Pulmonary Disease.

TL;DR: Standardized intensive multidrug treatment reduces disease progression and persistence in progressive Mycobacterium avium complex pulmonary disease and highlights the need for early diagnosis and treatment.
Journal ArticleDOI

First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.

TL;DR: In this paper, a single-centred retrospective cohort study was conducted to evaluate the long-term outcomes in 295 patients with MAC-PD following first line treatment with standard (RFP, EB, clarithromycin [CAM]) or alternative (EB and CAM with or without fluoroquinolones (FQs) or RFP, CAM, and FQs).
Journal ArticleDOI

Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease:A case report.

TL;DR: This case supports the idea that the presence of ILD could increase a risk for TRALI and therefore the eligibility for PE therapy of anti-MDA5 Ab-positive RP-ILD patients should be carefully evaluated given the risk of acute lung injury.
Journal ArticleDOI

The impact of adjuvant surgical treatment of nontuberculous mycobacterial pulmonary disease on prognosis and outcome.

TL;DR: NTM-PD patients who underwent adjuvant lung resection experienced overall favorable outcomes and achieved sputum culture conversion more frequently and long-term mortality may have been reduced by this procedure, and the level of GPL core antibody was shown to be a good clinical indicator of disease activity after surgery.